ATE417921T1 - Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies - Google Patents

Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies

Info

Publication number
ATE417921T1
ATE417921T1 AT04791706T AT04791706T ATE417921T1 AT E417921 T1 ATE417921 T1 AT E417921T1 AT 04791706 T AT04791706 T AT 04791706T AT 04791706 T AT04791706 T AT 04791706T AT E417921 T1 ATE417921 T1 AT E417921T1
Authority
AT
Austria
Prior art keywords
tacrolimus
production
streptomyces species
new streptomyces
new
Prior art date
Application number
AT04791706T
Other languages
English (en)
Inventor
Parveen Kumar
Sunita Sharma
Aniruddha Shukla
Sudeep Kumar
Raj Kumar Maurya
Vikas Katial
Ashoke Mitra
P Gigras
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE417921T1 publication Critical patent/ATE417921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT04791706T 2003-10-17 2004-10-15 Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies ATE417921T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1284DE2003 2003-10-17

Publications (1)

Publication Number Publication Date
ATE417921T1 true ATE417921T1 (de) 2009-01-15

Family

ID=34452218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791706T ATE417921T1 (de) 2003-10-17 2004-10-15 Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies

Country Status (7)

Country Link
US (1) US20070191415A1 (de)
EP (1) EP1751272B8 (de)
CN (1) CN1867664A (de)
AT (1) ATE417921T1 (de)
DE (1) DE602004018547D1 (de)
ES (1) ES2317066T3 (de)
WO (1) WO2005038009A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448984C (zh) * 2006-03-07 2009-01-07 广东省微生物研究所 粤蓝链霉菌
US7744717B2 (en) 2006-07-17 2010-06-29 E. I. Du Pont De Nemours And Company Process for enhancing the resolution of a thermally transferred pattern
CN101486975B (zh) * 2008-01-18 2012-04-18 浙江海正药业股份有限公司 一种链霉菌、用其产生他克莫司的方法及其应用
EP2272963A1 (de) 2009-07-09 2011-01-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung von Tacrolimus
KR101261131B1 (ko) 2010-08-24 2013-05-06 이화여자대학교 산학협력단 신규 타크롤리무스 유도체, 상기 유도체를 포함하는 신경 보호용 조성물, 상기 유도체를 포함하는 면역 억제용 조성물, 상기 유도체의 생산 방법 및 상기 유도체의 생산 균주
WO2012026665A1 (en) * 2010-08-24 2012-03-01 Ewha University - Industry Collaboration Foundation Novel tacrolimus derivatives, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same
RU2495937C1 (ru) * 2012-04-02 2013-10-20 Общество с ограниченной ответственностью "Фарминс"/Pharmins Ltd. (ООО "Фарминс"/Pharmins Ltd.) Способ получения такролимуса методом микробиологического синтеза
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
KR101729251B1 (ko) 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
CN118063537A (zh) 2015-09-08 2024-05-24 莫纳什大学 定向淋巴的前药
CN108384819B (zh) * 2017-02-03 2021-06-25 上海医药工业研究院 一种用于发酵他克莫司的培养基以及发酵方法
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP4306524A3 (de) 2017-08-29 2024-09-11 PureTech LYT, Inc. An das lymphatische system gerichtete lipidprodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
WO2019126374A1 (en) * 2017-12-19 2019-06-27 Ariya Therapeutics, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
CN108929335B (zh) * 2018-08-31 2021-07-20 福建省微生物研究所 一种他克莫司粗晶的制备方法
JP7810970B2 (ja) 2020-02-05 2026-02-04 シーポート・セラピューティクス・インコーポレイテッド 神経ステロイドの脂質プロドラッグ
CN112159826B (zh) * 2020-09-14 2022-05-24 浙江工业大学 一种提高他克莫司产量的方法
CN116515920A (zh) * 2023-05-08 2023-08-01 国药集团健康产业研究院有限公司 一种提高他克莫司产量的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137126A (en) * 1975-05-03 1979-01-30 Givaudan Corporation Process for preparing glucose isomerase using streptomyces glaucescens mutants
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5116756A (en) * 1991-01-28 1992-05-26 Merck & Co., Inc. Process for producing FK-506
US5194378A (en) * 1991-01-28 1993-03-16 Merck & Co., Inc. Process for producing fk-506
US5264355A (en) * 1992-07-02 1993-11-23 Merck & Co., Inc. Methlating enzyme from streptomyces MA6858

Also Published As

Publication number Publication date
EP1751272B8 (de) 2009-04-15
ES2317066T3 (es) 2009-04-16
WO2005038009A2 (en) 2005-04-28
WO2005038009A3 (en) 2005-06-16
EP1751272A2 (de) 2007-02-14
US20070191415A1 (en) 2007-08-16
EP1751272B1 (de) 2008-12-17
DE602004018547D1 (de) 2009-01-29
CN1867664A (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
DE602004018547D1 (de) Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
EP2402325A3 (de) Hydroxylierte und methoxylierte Cyclopenta[d]pyrimidine als AKT-Proteinkinase-Inhibitoren
MXPA02007137A (es) Fuente de tejido hepatico.
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
WO2008016738A3 (en) Antibacterial agents and related screening methods using small molecule macroarrays
EA200802213A1 (ru) Способы лечения заболеваний крови
MXPA05007462A (es) Derivados de pirrolopiridazina.
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004039248A3 (en) Repairing or replacing tissues or organs
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
DE60041876D1 (de) Polyurethanderivatzusammensetzungen und Verfahren zu ihrer Herstellung
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
NO20074723L (no) Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjon
WO2006055981A3 (en) Use of cutured three-dimensional tissue for treating congestive heart failure
DE602004021358D1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
FR2882751B1 (fr) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
EP1599128A4 (de) Verfahren zur behandlung von erkrankungen durch transplantation von entwickelnden allogenen oder xenogenen organen oder geweben
WO2004073375A3 (en) Podophyllotoxin derivatives as antitumor agents
ATE335475T1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1751272

Country of ref document: EP

REN Ceased due to non-payment of the annual fee